Clinical Trial Update: Sorafenib in Previously Treated Malignant Mesothelioma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating sorafenib in patients with previously treated malignant mesothelioma is described, with the trial status listed as unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Mesothelioma

Drugs mentioned

• Sorafenib (Sorafenib)

Snippet

Sponsor: King's College London | Conditions: Mesothelioma | Phase 2 | Status: UNKNOWN